Business Context and Reporting Period
Company: GlaxoSmithKline plc (GSK)
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: Six months ended June 30, 2007
Filing Date: July 30, 2007
This filing serves as a notification that GSK published its 2007 Half Year Report results via advertisements in the Financial Times, Daily Telegraph, and Wall Street Journal on July 26, 2007. The filing itself does not contain the detailed financial statements but directs investors to the company website (www.gsk.com) or the UK Listing Authority for the full report.
Key Financial Metrics
The provided text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The filing acts solely as a reference to the external publication of these results.
Material Changes
No material changes or comparative financial data are disclosed within this specific Form 6-K text. Investors must refer to the referenced Half Year Report advertisements for year-over-year comparisons.
Guidance, Outlook, and Risks
The filing text does not include management commentary, future guidance, risk factors, contingencies, or details on unusual items. These elements are contained within the full Half Year Report referenced in the document.
Investor Verification Checklist
- Verify the full 2007 Half Year Report on the GSK website (www.gsk.com) or at the UK Listing Authority's Document Viewing Facility.
- Confirm the specific financial results (revenue, net income, EPS) published in the July 26, 2007 advertisements.
- Review the full report for any material risk factors or forward-looking statements not summarized in this notification.